ROBO1, WNT5A, CDC42BPB

Size: px

Start display at page:

Download "ROBO1, WNT5A, CDC42BPB"

Ethan Rodgers
5 years ago
Views:

1 Downloaded from clincancerres.aacrjournals.org on March 20, American Association for Cancer

2 Downloaded from clincancerres.aacrjournals.org on March 20, American Association for Cancer

3 CDC42BPB ROBO1, WNT5A,

4 in-situ CDC42BPB ROBO1, WNT5A

5 Downloaded from clincancerres.aacrjournals.org on March 20, American Association for Cancer

6 xg xg μ μ xg μ μ μ μ

7 μ μ μ μ

8 QRICH1, CDC42BPB, DNMBP CDC42BPB ROBO1, WNT5A, CDC42BPB ROBO1 WNT5A CDC42BPB

9 Downloaded from clincancerres.aacrjournals.org on March 20, American Association for Cancer

10 vs. vs. CP, PLEKHS1, MYBPC1, ROBO1, RARRES1, WNT5A, AKR1C2, AR, IGFBP5, ENTPD5, SLC14A1, FBLN1, SYBU, STEAP2, GPD1L BPIFB1 vs. vs. QRICH1, CDC42BPB, USP39, ITSN1, and DNMBP DNMBP QRICH1, CDC42BPB WNT5A, RARRES1, ROBO1, CP, IGFBP5, PLEKHS1, BPIFB1,

11 MYBPC1 WNT5A, RARRES1, ROBO1 CP CDC42BPB DNMBP ROBO1, WNT5A CDC42BPB ROBO1 WNT5A CDC42BPB

12 ROBO1, WNT5A CDC42BPB

13 ROBO1 WNT5A CDC42BPB)

14 CP IGFBP5, ROBO1 WNT5A WNT5A WNT5A

15 in situ MDK IGFBP5 CXCR2 CDC2, HOXA13, IGF2 MAGEA WNT5A, CDC42BPB, ROBO1,

16 el al.

17 ROBO1, WNT5A CDC42BPB

18 Demographic features Average age (range) a Gender: male/ female, n BC-evaluation BC-surveillance Healthy/ other controls Clinicopathologic features b Biomarker Discovery Diagnostic Model Validation Grade Low c High Papillary Ta T1 Clinical St age T2 Papillary + CIS Ta T1 T2 CIS

19 Downloaded from clincancerres.aacrjournals.org on March 20, American Association for Cancer

20 ROBO1, WNT5A CDC42BPB Sensitivity Specificity All Cancer HG LG All Non-Cancer Negative BCevaluation Negative BC surveillance Healthy/ Other Controls Training Cohort Validation Cohort 3-Marker Panel Cytology a 3-Marker Panel Cytology a

21 ROBO1, WNT5A, CDC42BPB ROBO1, WNT5A, CDC42BPB

22 Downloaded from clincancerres.aacrjournals.org on March 20, American Association for Cancer

26 Downloaded from clincancerres.aacrjournals.org on March 20, American Association for Cancer

27 Downloaded from clincancerres.aacrjournals.org on March 20, American Association for Cancer

28 Downloaded from clincancerres.aacrjournals.org on March 20, American Association for Cancer

29 Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Mandy L Y Sin, Kathleen E Mach, Rahul Sinha Clin Cancer Res Published OnlineFirst February 13, Updated version Supplementary Material Author Manuscript Access the most recent version of this article at: doi: / ccr Access the most recent supplemental material at: Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. alerts Sign up to receive free -alerts related to this article or journal. Reprints and Subscriptions Permissions To order reprints of this article or to subscribe to the journal, contact the AACR Publications Department at pubs@aacr.org. To request permission to re-use all or part of this article, contact the AACR Publications Department at permissions@aacr.org.

The difference in cancer detection

in cancer detection 1 Introduction The difference in cancer detection Cxbladder Cxbladder is a non-invasive laboratory test for the detection of bladder cancer that gives you actionable results, which